Pharmaceutical Executive
CMS Signals Looming Sunshine Act Audits: How to Prepare
March 1, 2024
New guidance suggests that CMS may be ramping up Sunshine Act auditing activities, potentially resulting in monetary liability for noncompliant reporting entities.
After more than a decade of relative inactivity, the Centers for Medicare & Medicaid Services(CMS) has signaled that it may soon commence audits of reporting entities under the Sunshine Act.
Published by Pharmaceutical Executive on March 1, 2024, available at https://www.pharmexec.com/view/cms-signals-looming-sunshine-act-audits-how-to-prepare.
Contacts
Capabilities
Suggested News & Insights
Sidley Healthcare Investment Conference 2026Tuesday, September 22, 2026New York Ethics Opinion Addresses Ethical Limits on Attorney Participation in Whistleblower InvestigationsJuly 30, 2026The Evolving Global Landscape for Orphan Drug ExclusivityJuly 28, 2026Laboratory, Owners, and Investors Settle COVID-19 Testing Fraud Allegations for $24 MillionJuly 27, 2026DOJ Releases FOCUS Questionnaire to Assist in Evaluating Qui Tams Filed by Data MinersJuly 20, 2026Sidley Shortlisted in 16 Categories at the LMG Life Sciences Americas Awards 2026July 20, 2026
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory

